New fluid strategy aims to cut complications in High-Risk cancer surgery

NCT ID NCT06351475

Recruiting now Disease control Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

Summary

This study is testing if adding a protein solution called albumin to standard IV fluids during a major cancer surgery leads to fewer complications. It will involve 140 adults undergoing surgery for cancer that has spread to the abdominal lining. Researchers will compare the complication rates between patients who get the albumin mix and those who get standard fluids alone.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Gustave Roussy Institute
RECRUITING

Villejuif, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hôpital Hautepierre / UIC ARMO
RECRUITING

Strasbourg, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Institut régional du Cancer de Montpellier
RECRUITING

Montpellier, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
La Pitié Salpetriere hospital
RECRUITING

Paris, 75013, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Lariboisière hospital
RECRUITING

Paris, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Robert Debré hospital
RECRUITING

Reims, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Saint Louis hospital
RECRUITING

Paris, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

FLUID THERAPY HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY INTRAOPERATIVE CARE PERITONEAL NEOPLASMS POSTOPERATIVE COMPLICATIONS